Literature DB >> 8933875

Embolization with cellulose porous beads, II: Clinical trial.

J Hamada1, Y Kai, S Nagahiro, N Hashimoto, H Iwata, Y Ushio.   

Abstract

PURPOSE: To evaluate the clinical applicability of cellulose porous beads (CPBs) as an embolic material for permanent vascular occlusion.
METHODS: Embolization with CPBs was performed in 16 patients, six with meningioma of the sphenoid wing, two with meningioma of the falx, three with meningioma of the tentorium, two with dural arteriovenous fistula, one with paraganglioma, and two with spinal arteriovenous malformation. Surgical specimens were examined histologically.
RESULTS: No complications were encountered in any of the 16 patients. Angiograms obtained after embolization showed satisfactory vascular stasis in all cases. Histologic examination of surgical specimens disclosed that vessels having approximately the same caliber as the CPB particles were occluded without stretching of the vessel wall. Larger vessels were occluded by aggregates of many particles, which left no open spaces. Although a few inflammatory cells were seen in the thrombosed vessels, inflammation evoked by CPB was mild and did not extend to either the vessel wall or to surrounding tissues.
CONCLUSION: CPBs were easy to inject through microcatheters, traveled to distal sites, and produced homogeneous and peripheral embolization without inflammatory changes different from other embolic materials. CPBs are a good embolic material for permanent occlusion in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933875      PMCID: PMC8337550     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  The utility of the microcrystalline cellulose sphere as a particulate embolic agent: an experimental study.

Authors:  Y Kai; J Hamada; M Morioka; T Todaka; S Hasegawa; Y Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Clinical evaluation of cellulose porous beads for the therapeutic embolization of meningiomas.

Authors:  Y Kai; J-I Hamada; M Morioka; S Yano; H Nakamura; K Makino; T Mizuno; H Takeshima; J-I Kuratsu
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  Appropriate interval between embolization and surgery in patients with meningioma.

Authors:  Yutaka Kai; Jun-ichiro Hamada; Motohiro Morioka; Shigetoshi Yano; Tatemi Todaka; Yukitaka Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

4.  Preoperative cellulose porous beads for therapeutic embolization of meningioma: provocation test and technical considerations.

Authors:  Yutaka Kai; Jun-Ichiro Hamada; Motohiro Morioka; Shigetoshi Yano; Hideo Nakamura; Keishi Makino; Takamasa Mizuno; Hideo Takeshima; Jun-Ichi Kuratsu
Journal:  Neuroradiology       Date:  2007-02-22       Impact factor: 2.804

5.  Pre- and post-treatment MR imaging and single photon emission CT in patients with dural arteriovenous fistulas and retrograde leptomeningeal venous drainage.

Authors:  Yutaka Kai; Jun-ichiro Hamada; Motohiro Morioka; Tatemi Todaka; Takamasa Mizuno; Yukitaka Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

6.  A Case of Periodontal Necrosis following Embolization of Maxillary Artery for Epistaxis.

Authors:  Kohei Nishimoto; Ryosei Minoda; Ryoji Yoshida; Toshinori Hirai; Eiji Yumoto
Journal:  Case Rep Otolaryngol       Date:  2016-11-21

7.  Blood Compatibility of Sulfonated Cladophora Nanocellulose Beads.

Authors:  Igor Rocha; Jonas Lindh; Jaan Hong; Maria Strømme; Albert Mihranyan; Natalia Ferraz
Journal:  Molecules       Date:  2018-03-07       Impact factor: 4.411

8.  Successful transarterial embolization with cellulose porous beads for occipital haemangioma in an infant with Kasabach-Merritt syndrome.

Authors:  Zaw Aung Khant; Toshinori Hirai; Osamu Ikeda; Eiji Furukoji; Yoshihito Kadota; Minako Azuma; Norihiro Shinkawa; Keiji Kitatani; Yoichi Mizutani; Kimihiko Endo; Yasuyuki Yamashita
Journal:  BJR Case Rep       Date:  2017-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.